Interleukin-32β Stimulates migration of MDA-MB-231 and MCF-7cells via the VEGF-STAT3 signaling pathway

Cellular Oncology

Volumn 36, Issue 6, 2013, Pages 493-503

  Park, Jeong Su ^a   Choi, Su Yun ^b   Lee, Jeong Hyung ^c   Lee, Maria ^d   Nam, Eun Sook ^b   Jeong, Ae Lee ^a   Lee, Sunyi ^a   Han, Sora ^a   Lee, Myeong Sok ^a   Lim, Jong Seok ^a   Yoon, Do Young ^e   Kwon, Yongil ^d   Yang, Young ^a  

^a Sookmyung Women's University   (South Korea)

^b Hallym University College of Medicine   (South Korea)

^c Kangwon National University   (South Korea)

^d Hallym University   (South Korea)

^e Konkuk University   (South Korea)

Author keywords

Breast cancer; Interleukin 32; STAT3; VEGF

Indexed keywords

CYTOKINE; INTERLEUKIN 32BETA; MESSENGER RNA; SMALL INTERFERING RNA; STAT3 PROTEIN; TRANSCRIPTION FACTOR SLUG; UNCLASSIFIED DRUG; UVOMORULIN; VASCULOTROPIN; VIMENTIN;

ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER SIZE; CANCER STAGING; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIAL MESENCHYMAL TRANSITION; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SCORING SYSTEM; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; UMBILICAL VEIN ENDOTHELIAL CELL;

BREAST NEOPLASMS; CELL HYPOXIA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTERLEUKINS; LYMPHATIC METASTASIS; MCF-7 CELLS; NEOPLASM STAGING; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; U937 CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84890112683     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-013-0154-4     Document Type: Article

References (41)

1. S.H. Kim, S.Y. Han, T. Azam, D.Y. Yoon, C.A. Dinarello, Interleukin-32: a cytokine and inducer of TNFalpha. Immunity 22(1), 131-142 (2005)
2. P. Felaco, M.L. Castellani, M.A. De Lutiis, M. Felaco, F. Pandolfi, V. Salini, D. De Amicis, J. Vecchiet, S. Tete, C. Ciampoli, F. Conti, G. Cerulli, A. Caraffa, P. Antinolfi, C. Cuccurullo, A. Perrella, T.C. Theoharides, P. Conti, E. Toniato, D. Kempuraj, Y.B. Shaik, IL-32: a newly-discovered proinflammatory cytokine. J. Biol. Regul. Homeost. Agents 23(3), 141-147 (2009)
3. S.J. Na, S.H. So, K.O. Lee, Y.C. Choi, Elevated serum level of interleukin-32alpha in the patients with myasthenia gravis. J. Neurol. 258(10), 1865-1870 (2011)
4. P. Conti, P. Youinou, T.C. Theoharides, Modulation of autoimmunity by the latest interleukins (with special emphasis on IL-32). Autoimmun. Rev. 6(3), 131-137 (2007)
5. L.A. Joosten, M.G. Netea, S.H. Kim, D.Y. Yoon, B. Oppers-Walgreen, T.R. Radstake, P. Barrera, F.A. van de Loo, C.A. Dinarello, W.B. van den Berg, IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc. Natl. Acad. Sci. U. S. A. 103(9), 3298-3303 (2006)
6. N. Meyer, M. Zimmermann, S. Burgler, C. Bassin, S. Woehrl, K. Moritz, C. Rhyner, P. Indermitte, P. Schmid-Grendelmeier, M. Akdis, G. Menz, C.A. Akdis, IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis. J. Allergy Clin. Immunol. 125(4), 858-865 (2010). e810
7. M.G. Netea, T. Azam, E.C. Lewis, L.A. Joosten, M. Wang, D. Langenberg, X. Meng, E.D. Chan, D.Y. Yoon, T. Ottenhoff, S.H. Kim, C.A. Dinarello, Mycobacterium tuberculosis induces interleukin-32 production through a caspase- 1/IL-18/interferon-gamma-dependent mechanism. PLoS Med. 3(8), e277 (2006)
8. H. J. Jeong, S. Y. Shin, H. A. Oh, M. H. Kim, J. S. Cho, H. M. Kim, IL-32 up-regulation is associated with inflammatory cytokine production in allergic rhinitis. J. Pathol 224(4), 553-563 (2011)
9. B. Heinhuis, M.I. Koenders, F.A. van de Loo, M.G. Netea, W.B. van den Berg, L.A. Joosten, Inflammation-dependent secretion and splicing of IL-32{gamma} in rheumatoid arthritis. Proc. Natl. Acad. Sci. U. S. A. 108(12), 4962-4967 (2011)
10. A. R. Moschen, T. Fritz, A. D. Clouston, I. Rebhan, O. Bauhofer, H. D. Barrie, E. E. Powell, S. H. Kim, C. A. Dinarello, R. Bartenschlager, J. R. Jonsson, H. Tilg, Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis. Hepatology 53(6), 1819-1829 (2011)
11. C. Goda, T. Kanaji, S. Kanaji, G. Tanaka, K. Arima, S. Ohno, K. Izuhara, Involvement of IL-32 in activation-induced cell death in T cells. Int. Immunol. 18(2), 233-240 (2006)
12. N. Meyer, J. Christoph, H. Makrinioti, P. Indermitte, C. Rhyner, M. Soyka, T. Eiwegger, M. Chalubinski, K. Wanke, H. Fujita, P. Wawrzyniak, S. Burgler, S. Zhang, M. Akdis, G. Menz, C. Akdis, Inhibition of angiogenesis by IL-32: possible role in asthma. J. Allergy. Clin. Immunol. 129(4), 964-973 (2012)
13. B. Heinhuis, M.I. Koenders, W.B. van den Berg, M.G. Netea, C.A. Dinarello, L.A. Joosten, Interleukin 32 (IL-32) contains a typical alpha-helix bundle structure that resembles focal adhesion targeting region of focal adhesion kinase-1. J. Biol. Chem. 287(8), 5733-5743 (2012)
14. A. Nishida, A. Andoh, O. Inatomi, Y. Fujiyama, Interleukin-32 expression in the pancreas. J. Biol. Chem. 284(26), 17868-17876 (2009)
15. E.H. Seo, J. Kang, K.H. Kim, M.C. Cho, S. Lee, H.J. Kim, J.H. Kim, E.J. Kim, D.K. Park, S.H. Kim, Y.K. Choi, J.M. Kim, J.T. Hong, D.Y. Yoon, Detection of expressed IL-32 in human stomach cancer using ELISA and immunostaining. J. Microbiol. Biotechnol. 18(9), 1606-1612 (2008)
16. C. Sorrentino, E. Di Carlo, Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype. Am. J. Respir. Crit. Care Med. 180(8), 769-779 (2009)
17. H. Kobayashi, P.C. Lin, Molecular characterization of IL-32 in human endothelial cells. Cytokine 46(3), 351-358 (2009)
18. Y.H. Kang, M.Y. Park, D.Y. Yoon, S.R. Han, C.I. Lee, N.Y. Ji, P.K. Myung, H.G. Lee, J.W. Kim, Y.I. Yeom, Y.J. Jang, D.K. Ahn, E.Y. Song, Dysregulation of overexpressed IL-32alpha in hepatocellular carcinoma suppresses cell growth and induces apoptosis through inactivation of NF-kappaB and Bcl-2. Cancer Lett. 318(2), 226-233 (2012)
19. J.H. Oh, M.C. Cho, J.H. Kim, S.Y. Lee, H.J. Kim, E.S. Park, J.O. Ban, J.W. Kang, D.H. Lee, J.H. Shim, S.B. Han, D.C. Moon, Y.H. Park, D.Y. Yu, J.M. Kim, S.H. Kim, D.Y. Yoon, J.T. Hong, IL-32gamma inhibits cancer cell growth through inactivation of NF-kappaB and STAT3 signals. Oncogene 30(30), 3345-3359 (2011)
20. W. Remmele, H.E. Stegner, [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. Pathologe 8(3), 138-140 (1987)
21. K. Vuoriluoto, H. Haugen, S. Kiviluoto, J.P. Mpindi, J. Nevo, C. Gjerdrum, C. Tiron, J.B. Lorens, J. Ivaska, Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene 30(12), 1436-1448 (2011)
22. A. Shibata, T. Nagaya, T. Imai, H. Funahashi, A. Nakao, H. Seo, Inhibition of NF-kappaB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells. Breast Cancer Res. Treat. 73(3), 237-243 (2002)
23. S. Weis, J. Cui, L. Barnes, D. Cheresh, Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis. J. Cell Biol. 167(2), 223-229 (2004)
24. N.S. Brown, R. Bicknell, Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res. 3(5), 323-327 (2001)
25. L. Li, Y. Lu, Inhibition of Hypoxia-Induced Cell Motility by p16 in MDA-MB-231 Breast Cancer Cells. J. Cancer 1, 126-135 (2010)
26. M. Krol, K.M. Pawlowski, I. Dolka, O. Musielak, K. Majchrzak, J. Mucha, T. Motyl, Density of Gr1-positive myeloid precursor cells, p-STAT3 expression and gene expression pattern in canine mammary cancer metastasis. Vet. Res. Commun. 35(7), 409-423 (2011)
27. S. Zhang, H. E. Zhau, A. O. Osunkoya, S. Iqbal, X. Yang, S. Fan, Z. Chen, R. Wang, F. F. Marshall, L. W. Chung, D. Wu, Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cells. Mol. Cancer 9, 9 (2010)
28. S. Ishigami, T. Arigami, Y. Uchikado, T. Setoyama, Y. Kita, K. Sasaki, H. Okumura, H. Kurahara, Y. Kijima, A. Harada, S. Ueno, S. Natsugoe, IL-32 expression is an independent prognostic marker for gastric cancer. Med. Oncol. 30(2), 472 (2013)
29. M.G. Netea, T. Azam, G. Ferwerda, S.E. Girardin, M. Walsh, J.S. Park, E. Abraham, J.M. Kim, D.Y. Yoon, C.A. Dinarello, S.H. Kim, IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc. Natl. Acad. Sci. U. S. A. 102(45), 16309-16314 (2005)
30. C.A. Nold-Petry, M.F. Nold, J.A. Zepp, S.H. Kim, N.F. Voelkel, C.A. Dinarello, IL-32-dependent effects of IL-1beta on endothelial cell functions. Proc. Natl. Acad. Sci. U. S. A. 106(10), 3883-3888 (2009)
31. A.M. Marcondes, A.J. Mhyre, D.L. Stirewalt, S.H. Kim, C.A. Dinarello, H.J. Deeg, Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function. Proc. Natl. Acad. Sci. U. S. A. 105(8), 2865-2870 (2008)
32. R. Aesoy, B.C. Sanchez, J.H. Norum, R. Lewensohn, K. Viktorsson, B. Linderholm, An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells. Mol. Cancer Res. 6(10), 1630-1638 (2008)
33. M. Dal Monte, D. Martini, C. Ristori, D. Azara, C. Armani, A. Balbarini, P. Bagnoli, Hypoxia effects on proangiogenic factors in human umbilical vein endothelial cells: functional role of the peptide somatostatin. Naunyn Schmiedebergs Arch. Pharmacol. 383(6), 593-612 (2011)
34. G. Niu, K.L. Wright, M. Huang, L. Song, E. Haura, J. Turkson, S. Zhang, T. Wang, D. Sinibaldi, D. Coppola, R. Heller, L.M. Ellis, J. Karras, J. Bromberg, D. Pardoll, R. Jove, H. Yu, Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21(13), 2000-2008 (2002)
35. R.M. Neve, K. Chin, J. Fridlyand, J. Yeh, F.L. Baehner, T. Fevr, L. Clark, N. Bayani, J.P. Coppe, F. Tong, T. Speed, P.T. Spellman, S. DeVries, A. Lapuk, N.J. Wang, W.L. Kuo, J.L. Stilwell, D. Pinkel, D.G. Albertson, F.M. Waldman, F. McCormick, R.B. Dickson, M.D. Johnson, M. Lippman, S. Ethier, A. Gazdar, J.W. Gray, A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10(6), 515-527 (2006)
36. L. McInroy, A. Maatta, Down-regulation of vimentin expression inhibits carcinoma cell migration and adhesion. Biochem. Biophys. Res. Commun. 360(1), 109-114 (2007)
37. A.D. Yang, E.R. Camp, F. Fan, L. Shen, M.J. Gray, W. Liu, R. Somcio, T.W. Bauer, Y. Wu, D.J. Hicklin, L.M. Ellis, Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells. Cancer Res. 66(1), 46-51 (2006)
38. A.K. Sasser, N.J. Sullivan, A.W. Studebaker, L.F. Hendey, A.E. Axel, B.M. Hall, Interleukin-6 is a potent growth factor for ER-alpha-positive human breast cancer. FASEB J. 21(13), 3763-3770 (2007)
39. B. Wegiel, A. Bjartell, Z. Culig, J.L. Persson, Interleukin-6 activates PI3K/Akt pathway and regulates cyclin A1 to promote prostate cancer cell survival. Int. J. Cancer 122(7), 1521-1529 (2008)
40. T. Luedde, N. Beraza, V. Kotsikoris, G. van Loo, A. Nenci, R. De Vos, T. Roskams, C. Trautwein, M. Pasparakis, Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell 11(2), 119-132 (2007)
41. T. Sakurai, G. He, A. Matsuzawa, G.Y. Yu, S. Maeda, G. Hardiman, M. Karin, Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. Cancer Cell 14(2), 156-165 (2008)